Browsing Category
Pharma Industry News
4741 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Inhibrx Biosciences’ Ozekibart sets new benchmark in rare bone cancer treatment and advances toward 2026 BLA filing
Find out how Inhibrx Biosciences’ Ozekibart delivered breakthrough results in chondrosarcoma and is advancing toward a 2026 BLA filing—read more now!
Bladder cancer breakthrough: FDA gives Priority Review to Merck’s KEYTRUDA and KEYTRUDA QLEX + PADCEV combinations
Find out how Merck’s KEYTRUDA and new KEYTRUDA QLEX + PADCEV combinations are set to transform treatment for muscle-invasive bladder cancer — read more now
IM Cannabis to acquire 60% stake in quantum bio-data firm in up to US$54m deal
Find out how IM Cannabis is entering the quantum computing bio-data space—and what it could mean for investors and the company’s next growth phase.
Tango Therapeutics raises $225m in equity offering and PIPE to fuel precision oncology pipeline
Find out how Tango Therapeutics’ $225 M equity and PIPE financing could reshape its precision-oncology strategy and investor sentiment.
Scienture starts commercial rollout of Arbli, the first FDA-approved losartan oral suspension
Find out how Scienture is changing the hypertension treatment market with the FDA-approved Arbli losartan oral suspension.
Are short-acting psychedelics the next big bet in mental health? What pharma’s billion-dollar moves suggest
Are short-acting psychedelics the future of psychiatry? Pharma’s billion-dollar bets say yes. We explore what’s behind the new wave of scalable mental health drugs.
Ventyx Biosciences announces positive Phase 2 trial data for VTX3232 in obesity and cardiometabolic risk
Find out how Ventyx Biosciences’ VTX3232 is reshaping the obesity and cardiometabolic space through inflammation-targeted innovation.
Applied DNA Sciences makes bold crypto-biotech crossover with $17m BNB treasury and $58m funding
Find out how Applied DNA Sciences is redefining biotech strategy through a $17 million BNB treasury and $58 million private placement plan.
Positive IDWeek 2025 results highlight Armata’s AP-SA02 phage cocktail as a potential game-changer for Staph bacteremia
Find out how Armata Pharmaceuticals’ AP-SA02 phage therapy could redefine treatment for Staphylococcus aureus bloodstream infections.
Alvotech (NASDAQ: ALVO) reshuffles leadership as Anil Okay takes over Adalvo — is this a turning point for biosimilars?
Discover how Alvotech’s CCO Anil Okay’s move to Adalvo’s CEO seat could reshape commercial leadership, investor sentiment, and the global biosimilar race.